Skip to main content
ATEX
NASDAQ Technology

Officer files intent to sell over $10 million in shares after option exercise

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$83.01
Mkt Cap
$1.555B
52W Low
$17.58
52W High
$88.12
Market data snapshot near publication time

Summary

An Anterix Inc. officer plans to sell over $10 million worth of shares, acquired through option exercise, signaling a notable executive disposition.


Key Events

  • Officer Intent to Sell

    Christopher Guttman-McCabe, an officer, filed a Form 144 to sell 122,852 shares of common stock.

  • Significant Value

    The proposed sale is valued at approximately $10.04 million.

  • Option Exercise Related

    The shares were acquired through a stock option exercise on the same day as the proposed sale.

  • Executive Disposition

    This represents a substantial disposition by a key executive, following a pattern of other officers filing similar forms recently.


Analysis

Anterix Inc. officer Christopher Guttman-McCabe has filed a Form 144 indicating intent to sell 122,852 shares, valued at approximately $10.04 million. This proposed sale follows the exercise of stock options on the same day. The transaction represents a significant disposition by a key executive, occurring amidst recent positive news regarding spectrum license sales and FCC approvals, but also after a recent Q4 earnings miss. This is part of an ongoing pattern of officers filing Form 144s in recent months.

At the time of this filing, ATEX was trading at $83.01 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $17.58 to $88.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATEX - Latest Insights

ATEX
Jun 15, 2026, 4:51 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $83.01
Real-time Price: $83.01 info
Change: $0 (0%) info
Market Cap: $1.555B info
ATEX
Jun 10, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $65.00
Real-time Price: $83.01 info
Change: +$18.01 (+28%) info
Market Cap: $1.555B info
ATEX
Jun 10, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $67.77
Real-time Price: $83.01 info
Change: +$15.24 (+22%) info
Market Cap: $1.555B info
ATEX
May 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $56.80
Real-time Price: $83.01 info
Change: +$26.21 (+46%) info
Market Cap: $1.555B info
ATEX
Apr 21, 2026, 9:16 AM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $42.60
Real-time Price: $83.01 info
Change: +$40.41 (+95%) info
Market Cap: $1.555B info
ATEX
Apr 17, 2026, 4:09 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $42.19
Real-time Price: $83.01 info
Change: +$40.82 (+97%) info
Market Cap: $1.555B info
ATEX
Apr 16, 2026, 4:44 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $40.36
Real-time Price: $83.01 info
Change: +$42.65 (+106%) info
Market Cap: $1.555B info
ATEX
Apr 06, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $38.86
Real-time Price: $83.01 info
Change: +$44.15 (+114%) info
Market Cap: $1.555B info
ATEX
Apr 01, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.19
Real-time Price: $83.01 info
Change: +$44.82 (+117%) info
Market Cap: $1.555B info
ATEX
Mar 02, 2026, 5:39 PM EST
Filing Type: 144
Importance Score:
8
Price at Filing: $36.03
Real-time Price: $83.01 info
Change: +$46.98 (+130%) info
Market Cap: $1.555B info